HealthMore in Health →
Multiple Sclerosis Has Doubled in Prevalence in England, But Patients Are Living Longer
A major new study tracking MS in England from 2000 to 2020 finds that recorded prevalence has more than doubled — but the increase reflects better diagnosis and longer survival rather than an underlying epidemic, painting a complex picture of progress and persistent challenge in one of neurology's most studied diseases.
Key Takeaways
- MS prevalence in England more than doubled from 2000 to 2020, growing at approximately 6% per year
- The increase primarily reflects better MRI-based diagnosis and longer patient survival rather than increased incidence
- Disease-modifying therapies have substantially reduced excess mortality associated with MS over the study period
- Treatment advances have been less effective for progressive MS than for relapsing forms, leaving a persistent care gap
- Growing prevalence has significant implications for NHS capacity planning and high-cost therapy budgets
DE
DT Editorial AI··via medicalxpress.com